6th annual Bio/Pharmaceutical Cold Chain China 2015
About This Event
From July 1, 2013, newly established pharmaceutical trading enterprises and those applying for the reconstruction or expansion of their business premises and warehouses shall comply with the new requirements outlined in the Revised GSP Standards. Such enterprises will be issued the new Pharmaceutical Trading License and Pharmaceutical GSP Certificate if they are qualified.
By December 31, 2014, wholesale enterprises entrusted with drug storage and distribution and enterprises engaged in the wholesale of the following pharmaceutical products shall comply with the requirements prescribed by the Revised GSP Standards - Vaccines; Narcotic drugs; Psychotropic substances; Anabolic agents; and Peptide hormones.
Qualified enterprises will be issued the new Pharmaceutical Trading License and Pharmaceutical GSP Certificate, while for those failing to comply with the new standards, their corresponding business scope will be narrowed and relevant qualifications will be cancelled.
By December 31, 2015, all pharmaceutical trading enterprises must satisfy the new requirements regardless of the validity status of their Pharmaceutical Trading License and Pharmaceutical GSP Certificate.
From January 1, 2016, pharmaceutical trading enterprises that fail to meet the requirements prescribed by the Revised GSP Standards are not allowed to continue drug operation activities in the country.
To ensure that your pharmaceutical cold chain is in compliant with the new regulation, 6th Annual Bio/Pharmaceutical Cold Chain is going to gather 120+ senior practitioners from pharmaceutical manufacturers, distributors, 3rd party logistics providers and other solution providers to share the best practice improve the pharmaceutical cold chain quality in China.
Price:
Standard Conference Only: USD 1599
Time: On Tuesday April 14, 2015 at 8:00 am and ends Wednesday April 15, 2015 at 6:00 pm